Cue Biopharma is trading 6.35% down at $26.11, with no new company-specific catalyst identified for August 31, 2026.
- The decline follows a sharp late-August rally, including gains of 15.44% on August 25 and 7.81% on August 26.
- The latest major company update was second-quarter results released August 14.
- Broader markets are modestly lower amid geopolitical and interest-rate concerns.